Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Baxter corporation initiated important safety information regarding the infusor and intermate portable elastomeric infusion systems. contact manufacturer for a listing of all product codes affected. baxter has received complaints for infusion flow rates greater than intended for the referenced portable elastomeric infusion systems. in many cases the complaint details an overinfusion of medication that is the result of uses inconsistent with the instructions for use.